Key Metrics
5.3
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
70
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.87
5-Year SI
5-year SI
- N/A 2-year SI
- 0.82 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Surgery
SJR
- Q1 Surgery
- Q2 Oncology
- Q2 Hematology
- Q1 Medicine (miscellaneous)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.49
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
23%
4 to 6 months
52%
7 to 9 months
21%
Above 9 months
4%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
SJR
Topics Covered
- Cancer
- Lung cancer
- Progression-free survival
- Diagnostic accuracy
- Albumin
- Lymph node
- Overall survival
- Colorectal cancer
- Genotype
- Chemoradiotherapy
- Confidence interval
- Nivolumab
- Prostate cancer
- Hepatocellular carcinoma
- Quality of life
- Lymph node metastasis
- Area under the curve
- Computed tomography
- Saliva
- Adjuvant
Journal Specifications
| Overview | |
| Publisher | SPRINGER JAPAN KK |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1996 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in International Journal of Clinical Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study.
- 16 Nov 24
- International journal of clinical oncology
-
Full paper
Electronic patient-reported outcomes as digital therapeutics for patients with cancer: a narrative review of current practices and future directions.
- 16 Nov 24
- International journal of clinical oncology
-
Full paper
Phase Ib study of the oral PI3Kδ inhibitor linperlisib in patients with advanced solid tumors.
- 13 Nov 24
- International journal of clinical oncology
-
Full paper
Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.
- 12 Nov 24
- International journal of clinical oncology
-
Full paper
Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection.
- 11 Nov 24
- International journal of clinical oncology
-
Full paper
Lymphadenectomy and chemotherapy are effective treatments for patients with 2023 international federation of gynecology and obstetrics stage IIC-high risk endometrial cancer in Japan.
- 9 Nov 24
- International journal of clinical oncology
Scite analysis
Powered by scite_
3.7k articles received 46.5k citations see all
- 2,002 Supporting
- 43,068 Mentioning
- 415 Contrasting
Editorial notices
- 2 Retractions
- 0 Withdrawals
- 49 Corrections
- 48 Errata
- 0 Expression of Concern
FAQs
How long has International Journal of Clinical Oncology been actively publishing?
International Journal of Clinical Oncology has been in operation since 1996 till date.
What is the publishing frequency of International Journal of Clinical Oncology ?
International Journal of Clinical Oncology published with a Bi-monthly frequency.
How many articles did International Journal of Clinical Oncology publish last years ?
In 2023, International Journal of Clinical Oncology published 162 articles.
What is the eISSN & pISSN for International Journal of Clinical Oncology ?
For International Journal of Clinical Oncology,eISSN is 1437-7772 and pISSN is1341-9625.
What is Citescore for International Journal of Clinical Oncology ?
Citescore for International Journal of Clinical Oncology is 5.3.
What is H index for International Journal of Clinical Oncology ?
H index for International Journal of Clinical Oncology is 70.
What is SNIP score for International Journal of Clinical Oncology ?
SNIP score for International Journal of Clinical Oncology is 1.49.
What is the SJR for International Journal of Clinical Oncology ?
SJR for International Journal of Clinical Oncology is Q1.
Who is the publisher of International Journal of Clinical Oncology ?
SPRINGER JAPAN KK is the publisher of International Journal of Clinical Oncology.